TMCnet News
HLS Therapeutics to Webcast Live at Life Sciences Investor Forum December 17thTORONTO, Dec. 14, 2020 (GLOBE NEWSWIRE) -- HLS Therapeutics Inc. (“HLS” or the “Company”) (TSX:HLS), a specialty pharmaceutical company focusing on central nervous system and cardiovascular markets, today announced that Gilbert Godin, CEO, will present live at LifeSciencesInvestorForum.com on December 17th. DATE: Thursday, December 17th This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at www.lifesciencesinvestorforum.com. About HLS Therapeutics Inc. About Life Sciences Investor Forum A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network. HLS Contact: Dave Mason Investor Relations HLS Therapeutics Inc. (416) 247-9652 [email protected] Life Sciences Investor Forum John M. Viglotti SVP Corporate Services, Investor Access (212) 220-2221 [email protected] |